Replies to post #31445 on GeneSYS ID Inc fka GNID

[HokieHead]

While legitimate short-selling remains an accepted financial practice, manipulation by false rumors and naked short-selling has taken a serious toll on emerging industries. Biotechnology industry insiders have for years pleaded with the SEC to block the illegal short selling and false whisper campaigns that plague the industry. Smaller technology-driven companies frequently lack the resources to deal with attacks that drive down stock prices, crippling research and development budgets.

Yeah, okay exchange traded stocks. HAAHAA!! Keep at it...